ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselLYO-X AG
LYO-X AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of LYO-X AG is modeling and simulation as well as systems pharmacology for the preclinical and clinical development of biotherapeutics.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

LYO-X AG

✓ Offered11
Consulting and PK/PD Modelling Services
Strategic consulting and PK/PD modelling for the preclinical and clinical development of biotherapeutics, including systems pharmacology to support development decisions.
On Demand Phase I PK/PD Analysis
Pharmacokinetic, pharmacodynamic and biomarker analyses for Phase I studies to support dose escalation and interpretation of study results.
Target Assessment
Assessment of target structures as part of early biotherapeutic development, based on mechanistic PK/PD and systems pharmacology approaches.
Format Selection
Support with selecting the drug product format for biotherapeutics, e.g. for antibodies, bi-specifics, ADCs, nanobodies or Fab fragments.
Candidate Selection
Support in selecting candidates for preclinical and clinical development programmes based on PK/PD and systems pharmacology analyses.
Preclinical PK/PD and Toxicology Study Support
Planning and evaluation of preclinical PK/PD and GLP toxicology studies for the development and translation of biotherapeutics.
First Dose in Human / MABEL
Support in defining the first human dose via MABEL-based assessments for biotherapeutics.
Paediatric Dose Finding
Dose finding and dose derivation for paediatric studies based on PK/PD modelling.
Clinical Dose Finding Studies
Support for clinical dose-finding studies to select dose and regimen during the development process.
Due Diligence
Assessment of development projects and drug substance programmes within due-diligence analyses for biotherapeutics.
Biobetter Design and Benchmarking
Design and benchmarking of biobetter candidates for biotherapeutics based on mechanism of action, PK/PD and development goals.
Trust & reputation

ranQ Trust Score of LYO-X AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

LYO-X AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
LYO-X AG scores 82.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.92.512%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
LYO-X AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
LYO-X AG scores 20.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.20.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

LYO-X AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once LYO-X AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

LYO-X AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank LYO-X AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of LYO-X AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Holbeinstrasse 75
4051 Basel

At a glance

Legal form
Corporation
UID
CHE-272.466.019
Founded
2014 · 12 years
Last commercial register change
January 13, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    MS
    Medpace Switzerland AG
    Basel
    PS
    PreClinical Safety (PCS) Consultants Ltd
    Basel
    IS
    Immunovant Sciences GmbH
    Basel
    IP
    Ironwood Pharmaceuticals GmbH
    Basel
    PI
    PAREXEL International (CH) AG
    Basel
    WP
    Wright Pharma Consult
    Basel
    MA
    McArthur and Associates GmbH
    Basel
    3B
    3T Biosciences Europe GmbH
    Basel